Maternal antibiotic prophylaxis affects Bifidobact... - BV FAPESP
Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Maternal antibiotic prophylaxis affects Bifidobacterium spp. counts in the human milk, during the first week after delivery

Full text
Author(s):
Padilha, M. [1, 2] ; Iaucci, J. M. [1] ; Cabral, V. P. [1, 3] ; Diniz, E. M. A. [4] ; Taddei, C. R. [1, 5] ; Saad, I, S. M.
Total Authors: 6
Affiliation:
[1] I, Univ Sao Paulo, Sch Pharmaceut Sci, Av Prof Lineu Prestes 580, BR-05508000 Sao Paulo, SP - Brazil
[2] I, Univ Sao Paulo, Food Res Ctr FoRC, R Lago 250, BR-05508000 Sao Paulo, SP - Brazil
[3] Univ Sao Paulo, Sch Publ Hlth, Av Dr Arnaldo 715, BR-03178200 Sao Paulo, SP - Brazil
[4] Univ Sao Paulo, Med Sch, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP - Brazil
[5] Univ Sao Paulo, Sch Arts Sci & Humanities, Rua Arlindo Bettio 117, BR-03828000 Sao Paulo, SP - Brazil
Total Affiliations: 5
Document type: Journal article
Source: BENEFICIAL MICROBES; v. 10, n. 2, p. 155-163, 2019.
Web of Science Citations: 1
Abstract

Human milk is an important source of microorganisms for infant gut colonisation. Although the maternal antibiotic prophylaxis is an important strategy to prevent maternal/neonatal sepsis, it has to be investigated how it may affect the human milk microbiota, especially the genus Bifidobacterium, which has been associated to health benefits. Here, we investigated the impact of the maternal antibiotic prophylaxis on the human milk Bifidobacterium spp. and total bacteria counts, in the first week (short-term) and first month (medium-term) after delivery. Human milk samples were collected from 55 healthy lactating women recruited from the University Hospital of the University of Sao Paulo at days 7 +/- 3 and 30 +/- 4 after vaginal delivery. Twenty one volunteers had received maternal antibiotic prophylaxis (MAP group) and 34 had not received MAP (no-MAP group) during or after labour. Total DNA was isolated from milk samples, and the bacterial counts were estimated by quantitative PCR (qPCR). We found lower levels of Bdobacterium in the MAP group in the first week after delivery (median = 2.1 vs 2.4 log of equivalent cells/ml of human milk, for MAP and no-MAP groups, respectively; P=0.01), although there were no statistical differences in total bacteria count. However, no differences were found in Bifidobacterium counts between the groups at day 30 +/- 4 (median = 2.5 vs 2.2 log of equivalent cells/ml of human milk, for MAP and no-MAP groups, respectively; P=0.50). Our results suggest that MAP has a significant impact on Bifidobacterium counts in human milk, reducing this population in the first week after delivery. However, throughout the first month after delivery, the Bifidobacterium counts tend to recover, reaching similar counts to those found in no-MAP group at day 30 +/- 4 after delivery. (AU)

FAPESP's process: 16/07936-0 - Human milk microbiota analysis by next-generation sequencing: the impact of maternal diet and the intervention with fructooligosaccharides
Grantee:Marina Padilha
Support Opportunities: Scholarships abroad - Research Internship - Doctorate
FAPESP's process: 13/26435-3 - Impact of the maternal diet and the intervention with fructooligosaccharide on the human milk microbiota.
Grantee:Marina Padilha
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 13/07914-8 - FoRC - Food Research Center
Grantee:Bernadette Dora Gombossy de Melo Franco
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC